Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Andrew Winokur, MD, PhD Institute of Living, Hartford Hospital 200 Retreat Avenue Hartford, CT 06106 (860) 545-7956 or (860) 545-7502 The SearchLyte Program Dear NAMI of Massachusetts: We are writing to inform you that we are conducting a new program of clinical research studies in schizophrenia, called the SearchLyte Program. As you may be aware, it is believed that approximately 20% of schizophrenia patients experience predominant negative symptoms (such as feeling numb or empty inside, having little interest in life, and finding it hard to communicate), which often persist despite antipsychotic treatment. There is therefore an urgent medical need for the development of treatments specifically targeted at the negative symptoms of schizophrenia. Three of the studies in the SearchLyte Program are looking at whether a potential new investigational treatment, RO4917838, is effective and safe in treating the negative symptoms of schizophrenia when given with a patient’s usual antipsychotic medication. The studies will last for just over 1 year with regular clinic visits during this time. After that there will be an opportunity to receive the investigational study medication for a longer period of up to 3 years. To be eligible for the study, patients need to be ≥18 years of age and currently taking a typical or atypical antipsychotic (not clozapine); they must have been clinically stable for 5 months, and have a responsible caregiver who can ensure compliance with the study and its procedures. Participants need to have prominent and persistent negative symptoms despite taking their antipsychotic medications. I hope you will consider raising awareness about the SearchLyte Program to your community of patients with schizophrenia. We would be happy to provide you with further information – please do not hesitate to contact me at the address below. Sincerely Andrew Winokur, MD, PhD Principal Investigator The SearchLyte Study Team Institute of Living, Hartford Hospital 200 Retreat Avenue Hartford, CT 06106 Site-to-Advocacy-Group Letter V01.USA(EN).01